Tracer Kinetic Analysis of (S)-18F-THK5117 as a PET Tracer for Assessing Tau Pathology
暂无分享,去创建一个
Gunnar Antoni | My Jonasson | Jens Sörensen | Mark Lubberink | Jonas Eriksson | Anders Wall | Konstantinos Chiotis | Agneta Nordberg | M. Lubberink | A. Wall | G. Antoni | A. Nordberg | K. Chiotis | L. Saint‐Aubert | J. Sörensen | M. Jonasson | J. Eriksson | Laure Saint-Aubert | Helena Wilking | Margareta Sprycha | Beatrice Borg | Alf Thibblin | A. Thibblin | H. Wilking | Beatrice Borg | M. Sprycha
[1] Vincent J. Cunningham,et al. Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.
[2] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[3] Paul Edison,et al. A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[4] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[5] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] N. Volkow,et al. Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] Anton Forsberg,et al. The use of PIB-PET as a dual pathological and functional biomarker in AD. , 2012, Biochimica et biophysica acta.
[8] Olaf B. Paulson,et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps , 2005, NeuroImage.
[9] H. Arai,et al. Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease , 2013, The Journal of Nuclear Medicine.
[10] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[11] P. Vemuri,et al. Brain β-amyloid load approaches a plateau , 2013, Neurology.
[12] Nick C Fox,et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.
[13] Kazuhiko Yanai,et al. Tau PET Imaging in Alzheimer’s Disease , 2014, Current Neurology and Neuroscience Reports.
[14] Richard E Carson,et al. Noise Reduction in the Simplified Reference Tissue Model for Neuroreceptor Functional Imaging , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] Min-Ying Su,et al. Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807. , 2013, Journal of Alzheimer's disease : JAD.
[16] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[17] S. DeKosky,et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease , 2008, Brain : a journal of neurology.
[18] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[19] Christopher C Rowe,et al. Tau imaging: early progress and future directions , 2015, The Lancet Neurology.
[20] M. Hüll,et al. Dual-Biomarker Imaging of Regional Cerebral Amyloid Load and Neuronal Activity in Dementia with PET and 11C-Labeled Pittsburgh Compound B , 2011, The Journal of Nuclear Medicine.
[21] Bradley T. Hyman,et al. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.
[22] H. Akaike. A new look at the statistical model identification , 1974 .
[23] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[24] J. Trojanowski,et al. Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls , 2013, Neuron.